Gilead leukemia study gets complete response

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...

May 16, 2013 | Thursday | News
Fund freeze by Australia govt worries biotech

Singapore: AusBiotech calls on the Federal Government to provide some certainty to the innovation sector as support pro...

September 20, 2012 | Thursday | News
Projects under Indo-Australia Biotechnology Fund

...

May 18, 2012 | Friday | Analysis
FDA accepts resubmission of Moxduo NDA by QRxPharma

Singapore: The US Food and Drug Administration (FDA) has set August 26, 2013, as the date for action on QRxPharma's res...

March 15, 2013 | Friday | News
Mr Schwarz: We track samples at subzero degrees

Melbourne-based bluechiip is a tracking technology company that was listed on the Australia Stock Exchange in June 2011....

December 10, 2012 | Monday | Influencers
ASX biotech stock surge 54 percent in 2013

Singapore: Analysis from leading healthcare fund manager BioScience Managers has highlighted the outstanding year for bi...

January 7, 2014 | Tuesday | News
Aus Govt, Apotex sue Sanofi for extending patent

Singapore: The Australian government has joined hands with generics manufacturer Apotex in suing Sanofi Aventis seeking ...

April 22, 2013 | Monday | News
What functional roles do CROs play in APAC?

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...

September 18, 2013 | Wednesday | Analysis
Phosphagenics to begin oxymorphone patch trial

Singapore: Melbourne-based drug delivery technology company, Phosphagenics, is going to launch phase I study of a transd...

January 17, 2013 | Thursday | News
Massive cancer vaccination starts in Aus schools

Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers a...

February 22, 2013 | Friday | News
Patrys gets approval for myeloma trials in Australia

Singapore: Patrys has received approval to commence its planned phase I/IIa multiple myeloma trial with lead anti-canc...

November 5, 2012 | Monday | News
AtCor revenue up by 41 percent in FY 2013

Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central aortic blood pressur...

September 2, 2013 | Monday | Company results
Patrys cancer drug gives hope to patients

Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...

May 8, 2013 | Wednesday | News
Industry Records 11% Growth

Singapore: The bioscience industry in the major markets of Asia-Pacific region, excluding Japan and comprising Australia...

June 22, 2015 | Monday | Analysis
BSA-CMR Survey: New CRO players emerge in APAC

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...

September 18, 2013 | Wednesday | Analysis
ImmusanT starts trials of celiac disease vaccine, Nexvax2

Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first thera...

September 5, 2012 | Wednesday | News
Queensland marks 15% less HIV cases in 2013

Singapore: Ministerial Advisory Committee on HIV/AIDS (MAC) in Australia has achieved 15 percent reduction in HIV notifi...

September 6, 2013 | Friday | Analysis
Alchemia gets US patent for oncology platform technology

Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to ...

March 6, 2013 | Wednesday | News